G15

CAS No. 1161002-05-6

G15 ( —— )

Catalog No. M20708 CAS No. 1161002-05-6

G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 68 In Stock
10MG 113 In Stock
25MG 205 In Stock
50MG 350 In Stock
100MG 527 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    G15
  • Note
    Research use only not for human use.
  • Brief Description
    G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).
  • Description
    G15 is a cell-permeable non-steroidal antagonist of GPER (Ki = 20 nM).
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    GPER
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1161002-05-6
  • Formula Weight
    370.24
  • Molecular Formula
    C19H16BrNO2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (112.55 mM)
  • SMILES
    [H][C@]12CC=C[C@@]1([H])c1ccccc1N[C@H]2c1cc2OCOc2cc1Br
  • Chemical Name
    (3aS4R9bR)-4-(6-bromo-13-benzodioxol-5-yl)-3a459b-tetrahydro-3H-cyclopenta[c]quinoline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nayak T K Bologa C G Leitao A et al. In vivo effects of a GPR30 antagonist[J]. Nature Chemical Biology 2009 5(6):421-427.
molnova catalog
related products
  • Toremifene

    Toremifene (NK 622; FC 1157a) is a second-generation selective estrogen-receptor modulator (SERM) in development for the prevention of osteoporosis.

  • Acolbifene

    Acolbifene is a selective antagonist of estrogen receptors with IC50s of 2 nM and 0.4 nM for estradiol-induced transcriptional activity of ERα and ERβ. Acolbifene shows an anticarcinogenic property.

  • Diethylstilbestrol

    Diethylstilbestrol, a synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders.